View Alert
Originator: DHSC & NHS England and Improvement: Supply disruption alert

Issue date: 24-Oct-2019 14:06:30

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Mitomycin-C Kyowa all strengths: supply disruption

Broadcast content: Mitomycin-C 2mg, 10mg, 20mg powder for solution for injection and Mitomycin-C 40mg powder for intravesical solution marketed in the UK by Kyowa Kirin is unavailable with no date for resupply until further notice.

This alert provides advice on the management of patients currently using these medicines.


Please note: Supply Disruption Alerts (SDAs) relating to medicines are now co-badged as the Department of Health and Social Care and NHS England and Improvement as both organisations work together to develop these alerts.


Additional information: NHS England Regional Offices: please do not cascade to primary care

Alert reference: SDA/2019/006

Action underway deadline: 28-Oct-2019

Action complete deadline: 31-Jan-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency